nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—SLC6A4—chronic obstructive pulmonary disease	0.219	0.373	CbGaD
Mianserin—CYP1A2—chronic obstructive pulmonary disease	0.2	0.34	CbGaD
Mianserin—HTR2A—chronic obstructive pulmonary disease	0.168	0.287	CbGaD
Mianserin—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0265	0.15	CbGbCtD
Mianserin—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0257	0.145	CbGbCtD
Mianserin—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0257	0.145	CbGbCtD
Mianserin—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0229	0.129	CbGbCtD
Mianserin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0216	0.122	CbGbCtD
Mianserin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0146	0.0821	CbGbCtD
Mianserin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0139	0.0783	CbGbCtD
Mianserin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0124	0.0698	CbGbCtD
Mianserin—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.0076	0.218	CbGeAlD
Mianserin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00727	0.041	CbGbCtD
Mianserin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00687	0.0387	CbGbCtD
Mianserin—HTR7—pulmonary artery—chronic obstructive pulmonary disease	0.00442	0.127	CbGeAlD
Mianserin—Suicidal ideation—Roflumilast—chronic obstructive pulmonary disease	0.00312	0.029	CcSEcCtD
Mianserin—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00276	0.0791	CbGeAlD
Mianserin—Gynaecomastia—Roflumilast—chronic obstructive pulmonary disease	0.00196	0.0182	CcSEcCtD
Mianserin—Electrocardiogram QT prolonged—Formoterol—chronic obstructive pulmonary disease	0.00173	0.0161	CcSEcCtD
Mianserin—Electrocardiogram QT prolonged—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.0161	CcSEcCtD
Mianserin—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.0108	CcSEcCtD
Mianserin—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.0101	CcSEcCtD
Mianserin—Arthritis—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00957	CcSEcCtD
Mianserin—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00949	CcSEcCtD
Mianserin—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00099	0.00922	CcSEcCtD
Mianserin—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.000962	0.00896	CcSEcCtD
Mianserin—SLC6A3—respiratory system—chronic obstructive pulmonary disease	0.000957	0.0274	CbGeAlD
Mianserin—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.000948	0.00883	CcSEcCtD
Mianserin—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.000914	0.00851	CcSEcCtD
Mianserin—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.000896	0.00834	CcSEcCtD
Mianserin—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.000885	0.00824	CcSEcCtD
Mianserin—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.000885	0.00824	CcSEcCtD
Mianserin—SLC6A4—respiratory system—chronic obstructive pulmonary disease	0.000877	0.0251	CbGeAlD
Mianserin—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000859	0.008	CcSEcCtD
Mianserin—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.000835	0.00778	CcSEcCtD
Mianserin—Arthritis—Arformoterol—chronic obstructive pulmonary disease	0.000829	0.00772	CcSEcCtD
Mianserin—Arthritis—Formoterol—chronic obstructive pulmonary disease	0.000829	0.00772	CcSEcCtD
Mianserin—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.000822	0.0236	CbGeAlD
Mianserin—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.000814	0.00758	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.000809	0.00753	CcSEcCtD
Mianserin—HRH2—lung—chronic obstructive pulmonary disease	0.000777	0.0223	CbGeAlD
Mianserin—SLC6A2—respiratory system—chronic obstructive pulmonary disease	0.000772	0.0221	CbGeAlD
Mianserin—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000765	0.00713	CcSEcCtD
Mianserin—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000758	0.00706	CcSEcCtD
Mianserin—HTR7—respiratory system—chronic obstructive pulmonary disease	0.000744	0.0213	CbGeAlD
Mianserin—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000711	0.00662	CcSEcCtD
Mianserin—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000703	0.0202	CbGeAlD
Mianserin—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000699	0.0201	CbGeAlD
Mianserin—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.000679	0.00632	CcSEcCtD
Mianserin—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000674	0.00627	CcSEcCtD
Mianserin—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000673	0.00626	CcSEcCtD
Mianserin—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000667	0.00621	CcSEcCtD
Mianserin—HTR7—connective tissue—chronic obstructive pulmonary disease	0.000655	0.0188	CbGeAlD
Mianserin—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000646	0.00601	CcSEcCtD
Mianserin—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000643	0.00599	CcSEcCtD
Mianserin—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000627	0.00584	CcSEcCtD
Mianserin—Suicidal ideation—Prednisone—chronic obstructive pulmonary disease	0.000623	0.0058	CcSEcCtD
Mianserin—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000623	0.0058	CcSEcCtD
Mianserin—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000608	0.00566	CcSEcCtD
Mianserin—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000605	0.00564	CcSEcCtD
Mianserin—HTR7—smooth muscle tissue—chronic obstructive pulmonary disease	0.000599	0.0172	CbGeAlD
Mianserin—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000597	0.00556	CcSEcCtD
Mianserin—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000593	0.017	CbGeAlD
Mianserin—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000593	0.00552	CcSEcCtD
Mianserin—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000586	0.00546	CcSEcCtD
Mianserin—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000586	0.00546	CcSEcCtD
Mianserin—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000575	0.00536	CcSEcCtD
Mianserin—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000572	0.00532	CcSEcCtD
Mianserin—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000569	0.0163	CbGeAlD
Mianserin—ADRA2C—bronchus—chronic obstructive pulmonary disease	0.000563	0.0161	CbGeAlD
Mianserin—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00056	0.00521	CcSEcCtD
Mianserin—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000555	0.0159	CbGeAlD
Mianserin—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000553	0.00514	CcSEcCtD
Mianserin—HTR7—trachea—chronic obstructive pulmonary disease	0.00055	0.0158	CbGeAlD
Mianserin—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000548	0.0051	CcSEcCtD
Mianserin—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000548	0.0051	CcSEcCtD
Mianserin—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000546	0.00508	CcSEcCtD
Mianserin—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000539	0.00502	CcSEcCtD
Mianserin—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000537	0.005	CcSEcCtD
Mianserin—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000529	0.00492	CcSEcCtD
Mianserin—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000519	0.00483	CcSEcCtD
Mianserin—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000517	0.00482	CcSEcCtD
Mianserin—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000517	0.00482	CcSEcCtD
Mianserin—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000517	0.00482	CcSEcCtD
Mianserin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000516	0.00481	CcSEcCtD
Mianserin—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000512	0.00477	CcSEcCtD
Mianserin—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000512	0.00477	CcSEcCtD
Mianserin—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000512	0.00477	CcSEcCtD
Mianserin—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00051	0.00475	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000508	0.00473	CcSEcCtD
Mianserin—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000508	0.00473	CcSEcCtD
Mianserin—SLC6A3—lung—chronic obstructive pulmonary disease	0.000508	0.0146	CbGeAlD
Mianserin—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000507	0.00472	CcSEcCtD
Mianserin—ADRA2C—trachea—chronic obstructive pulmonary disease	0.000505	0.0145	CbGeAlD
Mianserin—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000502	0.00468	CcSEcCtD
Mianserin—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000502	0.00468	CcSEcCtD
Mianserin—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000501	0.00466	CcSEcCtD
Mianserin—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000492	0.00458	CcSEcCtD
Mianserin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000492	0.00458	CcSEcCtD
Mianserin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000492	0.00458	CcSEcCtD
Mianserin—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000491	0.00457	CcSEcCtD
Mianserin—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000491	0.00457	CcSEcCtD
Mianserin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000489	0.00455	CcSEcCtD
Mianserin—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000489	0.014	CbGeAlD
Mianserin—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.00455	CcSEcCtD
Mianserin—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000488	0.00455	CcSEcCtD
Mianserin—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000488	0.00455	CcSEcCtD
Mianserin—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000486	0.00453	CcSEcCtD
Mianserin—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000483	0.0045	CcSEcCtD
Mianserin—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000481	0.00448	CcSEcCtD
Mianserin—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.00048	0.0138	CbGeAlD
Mianserin—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000479	0.00446	CcSEcCtD
Mianserin—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000478	0.00445	CcSEcCtD
Mianserin—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000478	0.00445	CcSEcCtD
Mianserin—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000477	0.00444	CcSEcCtD
Mianserin—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000474	0.00442	CcSEcCtD
Mianserin—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000468	0.0134	CbGeAlD
Mianserin—SLC6A4—lung—chronic obstructive pulmonary disease	0.000465	0.0133	CbGeAlD
Mianserin—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000464	0.0133	CbGeAlD
Mianserin—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000461	0.00429	CcSEcCtD
Mianserin—HTR2B—lung—chronic obstructive pulmonary disease	0.000461	0.0132	CbGeAlD
Mianserin—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000455	0.00423	CcSEcCtD
Mianserin—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000455	0.00423	CcSEcCtD
Mianserin—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000449	0.0129	CbGeAlD
Mianserin—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000447	0.0128	CbGeAlD
Mianserin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000447	0.00416	CcSEcCtD
Mianserin—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000446	0.00415	CcSEcCtD
Mianserin—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000446	0.00415	CcSEcCtD
Mianserin—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000445	0.00415	CcSEcCtD
Mianserin—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000441	0.0041	CcSEcCtD
Mianserin—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000437	0.00407	CcSEcCtD
Mianserin—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.004	CcSEcCtD
Mianserin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000424	0.00395	CcSEcCtD
Mianserin—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000421	0.00392	CcSEcCtD
Mianserin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00042	0.00391	CcSEcCtD
Mianserin—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.0039	CcSEcCtD
Mianserin—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000419	0.0039	CcSEcCtD
Mianserin—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000415	0.00386	CcSEcCtD
Mianserin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000413	0.00385	CcSEcCtD
Mianserin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000413	0.00385	CcSEcCtD
Mianserin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000413	0.00385	CcSEcCtD
Mianserin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000413	0.00385	CcSEcCtD
Mianserin—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000412	0.00383	CcSEcCtD
Mianserin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.00383	CcSEcCtD
Mianserin—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.00383	CcSEcCtD
Mianserin—HRH1—trachea—chronic obstructive pulmonary disease	0.00041	0.0118	CbGeAlD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00041	0.00382	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00041	0.00382	CcSEcCtD
Mianserin—SLC6A2—lung—chronic obstructive pulmonary disease	0.00041	0.0117	CbGeAlD
Mianserin—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000408	0.0117	CbGeAlD
Mianserin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000405	0.00377	CcSEcCtD
Mianserin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000405	0.00377	CcSEcCtD
Mianserin—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000404	0.00376	CcSEcCtD
Mianserin—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000404	0.00376	CcSEcCtD
Mianserin—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000403	0.0116	CbGeAlD
Mianserin—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000403	0.00375	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000402	0.00374	CcSEcCtD
Mianserin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000396	0.00369	CcSEcCtD
Mianserin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.00369	CcSEcCtD
Mianserin—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00368	CcSEcCtD
Mianserin—HTR7—lung—chronic obstructive pulmonary disease	0.000395	0.0113	CbGeAlD
Mianserin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00039	0.00363	CcSEcCtD
Mianserin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00039	0.00363	CcSEcCtD
Mianserin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000388	0.00362	CcSEcCtD
Mianserin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000388	0.00362	CcSEcCtD
Mianserin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000388	0.00361	CcSEcCtD
Mianserin—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000387	0.0036	CcSEcCtD
Mianserin—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000387	0.0036	CcSEcCtD
Mianserin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00358	CcSEcCtD
Mianserin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00358	CcSEcCtD
Mianserin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000382	0.00355	CcSEcCtD
Mianserin—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000381	0.00355	CcSEcCtD
Mianserin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00038	0.00354	CcSEcCtD
Mianserin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00038	0.00354	CcSEcCtD
Mianserin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00351	CcSEcCtD
Mianserin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.00348	CcSEcCtD
Mianserin—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000373	0.0107	CbGeAlD
Mianserin—DRD2—lung—chronic obstructive pulmonary disease	0.000373	0.0107	CbGeAlD
Mianserin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00037	0.00345	CcSEcCtD
Mianserin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00037	0.00345	CcSEcCtD
Mianserin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000368	0.00343	CcSEcCtD
Mianserin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.00343	CcSEcCtD
Mianserin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.00342	CcSEcCtD
Mianserin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.0034	CcSEcCtD
Mianserin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00338	CcSEcCtD
Mianserin—ADRA2C—lung—chronic obstructive pulmonary disease	0.000363	0.0104	CbGeAlD
Mianserin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.00336	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000361	0.00336	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000353	0.00329	CcSEcCtD
Mianserin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000352	0.00328	CcSEcCtD
Mianserin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000352	0.00328	CcSEcCtD
Mianserin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.00325	CcSEcCtD
Mianserin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000348	0.00324	CcSEcCtD
Mianserin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000347	0.00323	CcSEcCtD
Mianserin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000345	0.00321	CcSEcCtD
Mianserin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000344	0.0032	CcSEcCtD
Mianserin—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000343	0.0032	CcSEcCtD
Mianserin—HTR2A—trachea—chronic obstructive pulmonary disease	0.000343	0.00983	CbGeAlD
Mianserin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00318	CcSEcCtD
Mianserin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00318	CcSEcCtD
Mianserin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00318	CcSEcCtD
Mianserin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00318	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.00317	CcSEcCtD
Mianserin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.00315	CcSEcCtD
Mianserin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000339	0.00315	CcSEcCtD
Mianserin—Mirtazapine—ADRB2—chronic obstructive pulmonary disease	0.000338	0.0784	CrCbGaD
Mianserin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000336	0.00313	CcSEcCtD
Mianserin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000335	0.00312	CcSEcCtD
Mianserin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000335	0.00311	CcSEcCtD
Mianserin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000333	0.0031	CcSEcCtD
Mianserin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000328	0.00306	CcSEcCtD
Mianserin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000328	0.00305	CcSEcCtD
Mianserin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000326	0.00304	CcSEcCtD
Mianserin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000326	0.00304	CcSEcCtD
Mianserin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000326	0.00304	CcSEcCtD
Mianserin—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000325	0.00303	CcSEcCtD
Mianserin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000325	0.00302	CcSEcCtD
Mianserin—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000324	0.00301	CcSEcCtD
Mianserin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00301	CcSEcCtD
Mianserin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.003	CcSEcCtD
Mianserin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00298	CcSEcCtD
Mianserin—CYP1A2—lung—chronic obstructive pulmonary disease	0.000315	0.00903	CbGeAlD
Mianserin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000309	0.00288	CcSEcCtD
Mianserin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000309	0.00288	CcSEcCtD
Mianserin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.00287	CcSEcCtD
Mianserin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000307	0.00286	CcSEcCtD
Mianserin—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000307	0.00286	CcSEcCtD
Mianserin—Mirtazapine—SLC6A4—chronic obstructive pulmonary disease	0.000307	0.0712	CrCbGaD
Mianserin—CYP2B6—lung—chronic obstructive pulmonary disease	0.000302	0.00866	CbGeAlD
Mianserin—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000302	0.00281	CcSEcCtD
Mianserin—Epinastine—HTR2A—chronic obstructive pulmonary disease	0.0003	0.0695	CrCbGaD
Mianserin—HRH1—lung—chronic obstructive pulmonary disease	0.000295	0.00846	CbGeAlD
Mianserin—ADRA2A—lung—chronic obstructive pulmonary disease	0.00029	0.00831	CbGeAlD
Mianserin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.00265	CcSEcCtD
Mianserin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000284	0.00265	CcSEcCtD
Mianserin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00028	0.00261	CcSEcCtD
Mianserin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.00261	CcSEcCtD
Mianserin—Mirtazapine—CYP1A2—chronic obstructive pulmonary disease	0.00028	0.0648	CrCbGaD
Mianserin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000278	0.00259	CcSEcCtD
Mianserin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000274	0.00256	CcSEcCtD
Mianserin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.0025	CcSEcCtD
Mianserin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00246	CcSEcCtD
Mianserin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00244	CcSEcCtD
Mianserin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00244	CcSEcCtD
Mianserin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000257	0.00239	CcSEcCtD
Mianserin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000256	0.00239	CcSEcCtD
Mianserin—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00235	CcSEcCtD
Mianserin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00233	CcSEcCtD
Mianserin—Rash—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00233	CcSEcCtD
Mianserin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00232	CcSEcCtD
Mianserin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00232	CcSEcCtD
Mianserin—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000249	0.00232	CcSEcCtD
Mianserin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00231	CcSEcCtD
Mianserin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00231	CcSEcCtD
Mianserin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.0023	CcSEcCtD
Mianserin—HTR2A—lung—chronic obstructive pulmonary disease	0.000246	0.00706	CbGeAlD
Mianserin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000245	0.00228	CcSEcCtD
Mianserin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000244	0.00228	CcSEcCtD
Mianserin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000243	0.00226	CcSEcCtD
Mianserin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.0022	CcSEcCtD
Mianserin—Mirtazapine—HTR2A—chronic obstructive pulmonary disease	0.000236	0.0547	CrCbGaD
Mianserin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.0022	CcSEcCtD
Mianserin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.00219	CcSEcCtD
Mianserin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00219	CcSEcCtD
Mianserin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00218	CcSEcCtD
Mianserin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.00215	CcSEcCtD
Mianserin—Cyproheptadine—HTR2A—chronic obstructive pulmonary disease	0.000229	0.053	CrCbGaD
Mianserin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000228	0.00212	CcSEcCtD
Mianserin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000227	0.00211	CcSEcCtD
Mianserin—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00208	CcSEcCtD
Mianserin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00201	CcSEcCtD
Mianserin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.002	CcSEcCtD
Mianserin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.00197	CcSEcCtD
Mianserin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00195	CcSEcCtD
Mianserin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00191	CcSEcCtD
Mianserin—Nortriptyline—SLC6A4—chronic obstructive pulmonary disease	0.000202	0.0468	CrCbGaD
Mianserin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00185	CcSEcCtD
Mianserin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000193	0.00179	CcSEcCtD
Mianserin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000192	0.00179	CcSEcCtD
Mianserin—Trimipramine—SLC6A4—chronic obstructive pulmonary disease	0.00019	0.044	CrCbGaD
Mianserin—Oxcarbazepine—ALB—chronic obstructive pulmonary disease	0.000189	0.0438	CrCbGaD
Mianserin—Nortriptyline—CYP1A2—chronic obstructive pulmonary disease	0.000184	0.0426	CrCbGaD
Mianserin—Desipramine—ADRB2—chronic obstructive pulmonary disease	0.000183	0.0424	CrCbGaD
Mianserin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.00165	CcSEcCtD
Mianserin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000177	0.00164	CcSEcCtD
Mianserin—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00163	CcSEcCtD
Mianserin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000172	0.0016	CcSEcCtD
Mianserin—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00159	CcSEcCtD
Mianserin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00156	CcSEcCtD
Mianserin—Desipramine—SLC6A4—chronic obstructive pulmonary disease	0.000166	0.0385	CrCbGaD
Mianserin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00154	CcSEcCtD
Mianserin—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00154	CcSEcCtD
Mianserin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00151	CcSEcCtD
Mianserin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00151	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000161	0.0015	CcSEcCtD
Mianserin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00145	CcSEcCtD
Mianserin—Nortriptyline—HTR2A—chronic obstructive pulmonary disease	0.000155	0.0359	CrCbGaD
Mianserin—Shock—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00143	CcSEcCtD
Mianserin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00142	CcSEcCtD
Mianserin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00142	CcSEcCtD
Mianserin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00141	CcSEcCtD
Mianserin—Desipramine—CYP1A2—chronic obstructive pulmonary disease	0.000151	0.0351	CrCbGaD
Mianserin—Trimipramine—HTR2A—chronic obstructive pulmonary disease	0.000146	0.0338	CrCbGaD
Mianserin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00132	CcSEcCtD
Mianserin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.00132	CcSEcCtD
Mianserin—Imipramine—SLC6A4—chronic obstructive pulmonary disease	0.000141	0.0326	CrCbGaD
Mianserin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00014	0.0013	CcSEcCtD
Mianserin—Amitriptyline—SLC6A4—chronic obstructive pulmonary disease	0.00014	0.0324	CrCbGaD
Mianserin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.00126	CcSEcCtD
Mianserin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.00126	CcSEcCtD
Mianserin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00125	CcSEcCtD
Mianserin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.00125	CcSEcCtD
Mianserin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00124	CcSEcCtD
Mianserin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000128	0.0012	CcSEcCtD
Mianserin—Imipramine—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.0297	CrCbGaD
Mianserin—Desipramine—HTR2A—chronic obstructive pulmonary disease	0.000128	0.0296	CrCbGaD
Mianserin—Amitriptyline—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.0295	CrCbGaD
Mianserin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000112	0.00104	CcSEcCtD
Mianserin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00103	CcSEcCtD
Mianserin—Imipramine—HTR2A—chronic obstructive pulmonary disease	0.000108	0.0251	CrCbGaD
Mianserin—Amitriptyline—HTR2A—chronic obstructive pulmonary disease	0.000108	0.0249	CrCbGaD
Mianserin—Nortriptyline—ALB—chronic obstructive pulmonary disease	0.000106	0.0246	CrCbGaD
Mianserin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00096	CcSEcCtD
Mianserin—Rash—Prednisone—chronic obstructive pulmonary disease	9.83e-05	0.000915	CcSEcCtD
Mianserin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.82e-05	0.000914	CcSEcCtD
Mianserin—Headache—Prednisone—chronic obstructive pulmonary disease	9.77e-05	0.000909	CcSEcCtD
Mianserin—Amitriptyline—ALB—chronic obstructive pulmonary disease	7.36e-05	0.0171	CrCbGaD
Mianserin—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.84e-06	9.95e-05	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	8.84e-06	9.94e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.83e-06	9.93e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.79e-06	9.89e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.71e-06	9.8e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.67e-06	9.76e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.66e-06	9.74e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.66e-06	9.74e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.61e-06	9.69e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.6e-06	9.68e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.57e-06	9.65e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.56e-06	9.64e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.55e-06	9.63e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.55e-06	9.62e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.54e-06	9.61e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.49e-06	9.55e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.48e-06	9.54e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.38e-06	9.42e-05	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.37e-06	9.42e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.33e-06	9.38e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.32e-06	9.36e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.32e-06	9.36e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.31e-06	9.35e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.28e-06	9.31e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.28e-06	9.31e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.24e-06	9.27e-05	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.23e-06	9.27e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.23e-06	9.26e-05	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.22e-06	9.25e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.17e-06	9.2e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.16e-06	9.18e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.16e-06	9.18e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.15e-06	9.17e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.15e-06	9.17e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.11e-06	9.13e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.09e-06	9.11e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.01e-06	9.01e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.99e-06	8.99e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.97e-06	8.97e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.9e-06	8.89e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.83e-06	8.82e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.81e-06	8.79e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.8e-06	8.78e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.79e-06	8.76e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.78e-06	8.75e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.73e-06	8.7e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.69e-06	8.66e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.65e-06	8.61e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.62e-06	8.57e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.6e-06	8.55e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.55e-06	8.5e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.53e-06	8.47e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.49e-06	8.43e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.48e-06	8.41e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.47e-06	8.41e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.46e-06	8.4e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.44e-06	8.38e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.44e-06	8.38e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.44e-06	8.37e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.43e-06	8.36e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.41e-06	8.34e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.31e-06	8.23e-05	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	7.27e-06	8.19e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.27e-06	8.18e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.26e-06	8.17e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.13e-06	8.03e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.13e-06	8.02e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.11e-06	8e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.02e-06	7.9e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.01e-06	7.89e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	6.97e-06	7.85e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.93e-06	7.79e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.91e-06	7.77e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.9e-06	7.76e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.87e-06	7.73e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.85e-06	7.71e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.8e-06	7.65e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.76e-06	7.6e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.76e-06	7.6e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.71e-06	7.55e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	6.67e-06	7.51e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.66e-06	7.5e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.65e-06	7.48e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.63e-06	7.46e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.61e-06	7.44e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.58e-06	7.41e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.58e-06	7.4e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.57e-06	7.39e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.56e-06	7.38e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.55e-06	7.37e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.52e-06	7.34e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.52e-06	7.33e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.5e-06	7.32e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.34e-06	7.13e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.33e-06	7.12e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.3e-06	7.09e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.29e-06	7.08e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.25e-06	7.04e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.25e-06	7.03e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.24e-06	7.02e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.23e-06	7.01e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.2e-06	6.98e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.15e-06	6.92e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.12e-06	6.89e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.05e-06	6.8e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.04e-06	6.79e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.02e-06	6.78e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.01e-06	6.76e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6e-06	6.75e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.97e-06	6.72e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.88e-06	6.62e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.87e-06	6.6e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.84e-06	6.57e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.81e-06	6.54e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.76e-06	6.49e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.73e-06	6.45e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.73e-06	6.44e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.7e-06	6.42e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.69e-06	6.41e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	5.66e-06	6.37e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.61e-06	6.31e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.6e-06	6.31e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.58e-06	6.28e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.58e-06	6.28e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.57e-06	6.26e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.55e-06	6.25e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.53e-06	6.22e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.47e-06	6.15e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.45e-06	6.14e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.43e-06	6.11e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	5.42e-06	6.1e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	5.31e-06	5.98e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.31e-06	5.97e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.3e-06	5.97e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.3e-06	5.96e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.3e-06	5.96e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.28e-06	5.94e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.22e-06	5.88e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.22e-06	5.87e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.21e-06	5.86e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.2e-06	5.86e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.15e-06	5.79e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.14e-06	5.79e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.12e-06	5.76e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.12e-06	5.76e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.11e-06	5.75e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.11e-06	5.75e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.09e-06	5.72e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.08e-06	5.72e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.06e-06	5.69e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.06e-06	5.69e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.05e-06	5.68e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.04e-06	5.67e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.04e-06	5.67e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.01e-06	5.64e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.98e-06	5.6e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.97e-06	5.59e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.97e-06	5.59e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.95e-06	5.57e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.89e-06	5.5e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.86e-06	5.47e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.85e-06	5.46e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.84e-06	5.44e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.79e-06	5.39e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.76e-06	5.36e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.75e-06	5.34e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.7e-06	5.29e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.7e-06	5.29e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.62e-06	5.2e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.61e-06	5.19e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.6e-06	5.18e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.6e-06	5.18e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.53e-06	5.1e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.49e-06	5.05e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.47e-06	5.04e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.42e-06	4.97e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.41e-06	4.96e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.37e-06	4.92e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.3e-06	4.84e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.3e-06	4.84e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.29e-06	4.82e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.27e-06	4.8e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.24e-06	4.77e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.23e-06	4.76e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.21e-06	4.73e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.2e-06	4.73e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.19e-06	4.72e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.15e-06	4.67e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.13e-06	4.65e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.07e-06	4.59e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.06e-06	4.57e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.02e-06	4.52e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.02e-06	4.52e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.02e-06	4.52e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4e-06	4.5e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.99e-06	4.49e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.95e-06	4.44e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.94e-06	4.43e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.88e-06	4.37e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.88e-06	4.36e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.87e-06	4.36e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.87e-06	4.35e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.85e-06	4.33e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.82e-06	4.3e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.81e-06	4.29e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.79e-06	4.27e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.74e-06	4.21e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.74e-06	4.21e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.72e-06	4.18e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.69e-06	4.15e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.69e-06	4.15e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.65e-06	4.1e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.63e-06	4.09e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.62e-06	4.07e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.6e-06	4.05e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.59e-06	4.04e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.58e-06	4.03e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.55e-06	3.99e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.54e-06	3.99e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.53e-06	3.97e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.35e-06	3.77e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.3e-06	3.71e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.29e-06	3.71e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.29e-06	3.7e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.28e-06	3.69e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.26e-06	3.67e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.25e-06	3.66e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.23e-06	3.63e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.22e-06	3.62e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.14e-06	3.53e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.13e-06	3.52e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.12e-06	3.51e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.04e-06	3.42e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3e-06	3.37e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.99e-06	3.37e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.98e-06	3.35e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.94e-06	3.31e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.87e-06	3.23e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.86e-06	3.22e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.78e-06	3.13e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.75e-06	3.1e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.71e-06	3.05e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.7e-06	3.04e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.52e-06	2.84e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.48e-06	2.79e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.48e-06	2.79e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.47e-06	2.77e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.41e-06	2.72e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.31e-06	2.6e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.26e-06	2.54e-05	CbGpPWpGaD
